Your search history is turned on.
Date: April 19, 2024 Jurisdictions: British Columbia, Ontario
_ Form 52-109FV2 Certification of interim filings - venture issuer basic certificate I, Guy Bourgeois, Chief Financial Officer of Orion Nutraceuticals Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Orion Nutraceuticals Inc. (the issuer...
_ Form 52-109FV2 Certification of interim filings - venture issuer basic certificate I, Guy Bourgeois, Chief Executive Officer of Orion Nutraceuticals Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Orion Nutraceuticals Inc. (the issuer...
STIRLING EXPLORATION LTD ORION NUTRACEUTICALS INC. Management Discussion and Analysis Periods Ended February 29, 2024 and February 28, 2023 OVERVIEW The following management discussion and analysis (MDA) of the financial position of Orion Nutraceuticals Inc. (the Company or the Issuer), and results of operations prepared on April 19, 2024, s...
ORION NUTRACEUTICALS INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED FEBRUARY 29, 2024 AND FEBRUARY 28, 2023 (Expressed in Canadian Dollars) (Unaudited prepared by management) Notice to...
Date: March 13, 2024 Jurisdictions: British Columbia, Ontario
MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Reporting Issuer Orion Nutraceuticals Inc. (the Company) 1890 1075 West Georgia Street Vancouver, BC V6E 3C9 Item 2: Date of Material Change March 13, 2024 Item 3: News Release A news release was issued and disseminated ...
NEWS RELEASE Orion Nutraceuticals Announces Management Changes Vancouver, British Columbia March 13, 2024 Orion Nutraceuticals Inc., (CSE: ORI) (the Company or Orion) announces the resignation of Joel Dumaresq as Director, Chief Executive Officer and Chief Financial Officer of the Company. Following Mr. Dumares...
Date: January 16, 2024 Jurisdictions: British Columbia, Ontario
ORION NUTRACEUTICALS INC. INTERIM FINANCIAL STATEMENTS ANNUAL FINANCIAL STATEMENTS Mark this box if you would like to receive Mark this box if you would like to receive Interim Financial Statements by mail. Annual Financial Statements by mail. Financial Statements Request Form Under securities regulations, a reporting issuer must send a...
ORION NUTRACEUTICALS INC. Security Class: Common Shares FORM OF PROXY Annual General & Special Meeting to be held on Thursday, February 8, 2024 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to atten...
P a g e | 1 ORION NUTRACEUTICALS INC. ANNUAL GENERAL & SPECIAL MEETING Notice of Annual General Meeting & Special of Shareholders and Information Circular As of January 4, 2024 P a g e | 2 ORION NUTRACEUTICALS INC. Suite 1890 1075 West Georgi...
P a g e | 2 ORION NUTRACEUTICALS INC. Suite 1890 1075 West Georgia Street Vancouver, British Columbia, V6E 3C9, Canada NOTICE OF ANNUAL GENERAL & SPECIAL MEETING OF SHAREHOLDERS NOTICE IS GIVEN that the Annual General & Special Meeting (the Meeting) of the shareholders of Orion Nutraceuticals Inc....